BIT
IRWD icon

BlackRock Institutional Trust’s Ironwood Pharmaceuticals IRWD Stock Holding History

BlackRock Institutional Trust’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$54.3M Buy
4,237,465
+254,739
+6% +$3.22M 0.01% 1296
2016
Q3 		$53M Buy
3,982,726
+50,288
+1% +$588K 0.01% 1265
2016
Q2 		$43.1M Buy
3,932,438
+76,998
+2% +$752K 0.01% 1329
2016
Q1 		$35.3M Buy
3,855,440
+10,805
+0.3% +$89.1K 0.01% 1443
2015
Q4 		$37.3M Buy
3,844,635
+206,906
+6% +$2M 0.01% 1441
2015
Q3 		$31.7M Sell
3,637,729
-48,972
-1% -$457K 0.01% 1517
2015
Q2 		$37.2M Sell
3,686,701
-161,177
-4% -$1.87M 0.01% 1478
2015
Q1 		$51.6M Buy
3,847,878
+2,626
+0.1% +$34.5K 0.01% 1300
2014
Q4 		$49.3M Buy
3,845,252
+30,503
+0.8% +$349K 0.01% 1308
2014
Q3 		$41.4M Sell
3,814,749
-89,550
-2% -$1.03M 0.01% 1378
2014
Q2 		$50.1M Buy
3,904,299
+118,902
+3% +$1.29M 0.01% 1328
2014
Q1 		$39.1M Buy
3,785,397
+427,861
+13% +$4.81M 0.01% 1471
2013
Q4 		$32.6M Buy
3,357,536
+139,004
+4% +$1.25M 0.01% 1573
2013
Q3 		$31.9M Buy
3,218,532
+219,272
+7% +$2.15M 0.01% 1515
2013
Q2 		$24.9M Buy
+2,999,260
New +$36.4M 0.01% 1636

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock Institutional Trust's IRWD Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Ironwood Pharmaceuticals (IRWD) stake by 6.4% in Q4 2016, buying an estimated $3.22M and bringing the position to 4,237,465 shares worth $54.3M. The position accounts for 0.01% of the portfolio, ranked #1296.

BlackRock Institutional Trust first reported a position in IRWD in Q2 2013 and has held it in 15 quarters since. 163 funds tracked by Wall St. Rank hold IRWD as of Q4 2016.

  • BlackRock Institutional Trust held 4,237,465 shares of Ironwood Pharmaceuticals worth $54.3M as of Q4 2016.
  • BlackRock Institutional Trust bought 254,739 Ironwood Pharmaceuticals shares in Q4 2016, an estimated $3.22M.
  • Ironwood Pharmaceuticals made up 0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1296 holding.
  • BlackRock Institutional Trust first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • 163 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.